scholarly journals Extracellular vesicle-mediated amyloid transfer to neural progenitor cells: implications for RAGE and HIV infection

2020 ◽  
Vol 13 (1) ◽  
Author(s):  
Ibolya E. András ◽  
Marta Garcia-Contreras ◽  
Christopher Yanick ◽  
Paola Perez ◽  
Brice Sewell ◽  
...  
2020 ◽  
Author(s):  
Ibolya E. András ◽  
Marta Garcia-Contreras ◽  
Christopher Yanick ◽  
Paola Perez ◽  
Brice Sewell ◽  
...  

Abstract Amyloid beta (Aβ) deposition was demonstrated to be elevated in the brains of HIV-infected patients and associated with neurocognitive decline; however, the mechanisms of these processes are poorly understood. The goal of the current study was to address the hypothesis that Aβ can be transferred via extracellular vesicles (ECVs) from brain endothelial cells to neural progenitor cells (NPCs) and that this process can contribute to abnormal NPC differentiation. Mechanistically, we focused on the role of the receptor for advanced glycation endproducts (RAGE) and activation of the inflammasome in these events. ECVs loaded with Aβ (Aβ-ECVs) were readily taken up by NPCs and Aβ partly colocalized with the inflammasome markers ASC and NLRP3 in the nuclei of the recipient NPCs. This colocalization was affected by HIV and RAGE inhibition by a high-affinity specific inhibitor FPS-ZM1. Blocking RAGE resulted also in an increase in ECV number produced by brain endothelial cells, decreased Aβ content in ECVs, and diminished Aβ-ECVs transfer to NPC nuclei. Interestingly, both Aβ-ECVs and RAGE inhibition altered NPC differentiation. Overall, these data indicate that RAGE inhibition affects brain endothelial ECV release and Aβ-ECVs transfer to NPCs. These events may modulate ECV-mediated amyloid pathology in the HIV-infected brain and contribute to the development of HIV-associated neurocognitive disorders.


2019 ◽  
Author(s):  
Ibolya E. András ◽  
Marta Garcia-Contreras ◽  
Christopher Yanick ◽  
Paola Perez ◽  
Brice Sewell ◽  
...  

Abstract Amyloid beta (Aβ) deposition was demonstrated to be elevated in the brains of HIV-infected patients and associated with neurocognitive decline; however, the mechanisms of these processes are poorly understood. The goal of the current study was to address the hypothesis that Aβ can be transferred via extracellular vesicles (ECVs) from brain endothelial cells to neural progenitor cells (NPCs) and that this process can contribute to abnormal NPC differentiation. Mechanistically, we focused on the role of the receptor for advanced glycation endproducts (RAGE) and activation of the inflammasome in these events. ECVs loaded with Aβ (Aβ-ECVs) were readily taken up by NPCs and Aβ partly colocalized with the inflammasome markers ASC and NLRP3 in the nuclei of the recipient NPCs. This colocalization was affected by HIV and RAGE inhibition by a high-affinity specific inhibitor FPS-ZM1. Blocking RAGE resulted also in an increase in ECV number produced by brain endothelial cells, decreased Aβ content in ECVs, and diminished Aβ-ECVs transfer to NPC nuclei. Interestingly, both Aβ-ECVs and RAGE inhibition altered NPC differentiation. Overall, these data indicate that RAGE inhibition affects brain endothelial ECV release and Aβ-ECVs transfer to NPCs. These events may modulate ECV-mediated amyloid pathology in the HIV-infected brain and contribute to the development of HIV-associated neurocognitive disorders.


2020 ◽  
Author(s):  
Minseon Park ◽  
William Baker ◽  
Dilraj Cambow ◽  
Danielle Gogerty ◽  
Ana Rachel Leda ◽  
...  

Abstract BackgroundMaintaining an intact pool of neural progenitor cells (NPCs) is crucial for generating new and functionally active neurons. As intrinsic and microenvironments tightly control developmental processes of adult neurogenesis, Methamphetamine (METH) and HIV-1-mediated impairment of the blood-brain barrier and development of neuroinflammation may induce alterations in functions of NPCs; however, the combined effects of METH and HIV-1 on the NPCs are still poorly understood.MethodsTo elucidate the possible mechanisms for the enhanced proliferation of NPCs by METH exposure and HIV infection, Male C57BL/6 mice were injected with METH with an escalating dose regimen for 6 days, followed by infusion with a chimeric HIV-NDK (EcoHIV) into the left internal carotid artery to infect brains. NPCs were isolated from the subventricular zone (SVZ) and used for RNA sequencing and differential expression analysis two weeks after infection. ReNcell VM, an immortalized human NPC line were used for in vitro exposure to METH and HIV infectionResultsChronic exposure to METH combined with brain infection by EcoHIV enhanced the proliferation of NPCs in the SVZ in mice. This effect was long-lasting as it was preserved ex vivo in NPCs isolated from the exposed mice over several passages in the absence of additional treatments. Transcriptomic studies indicated that 27 out of the top 30 differentially expressed genes response to METH plus EcoHIV were targets of the Forkhead box O transcriptional factor (FOXO), and primarily FOXO3. Additional ex vivo studies and in vitro experiments revealed the upregulation of the CXCL12-CXCR4 axis, leading to activation of downstream pAkt and pErk, the pathways that can phosphorylate FOXO3 and force its exports from the nuclei into the cytoplasm. Indeed, nuclear expulsion of FOXO3 was demonstrated both in mice exposed to METH and infected with EcoHIV and in cell culture of human NPCs.ConclusionsThese results provide novel information that exposure to METH combined with HIV infection can induce aberrant proliferation of SVZ-derived NPCs. Upregulation of CXCL12-CXCR4-Akt-1 signaling pathway exported FOXO3 into the cytoplasm, which changed the mRNA expression of FOXO3-target genes and induced the proliferation alteration as a result.


Sign in / Sign up

Export Citation Format

Share Document